Form 4 for EFX Equifax
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0001225208-22-002207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-11 | EFX | Singh Sid | Pres - USIS | A - Grant | $0.00 | +3,112 | 13.3K | +31% | $0 |
| D | 2022-02-15 | 2022-02-11 | EFX | Singh Sid | Pres - USIS | A - Grant | $0.00 | +12.4K | 12.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | A | A | 3,112 | $0.00 | 13,313 | D | — | — | (F1) Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Derivative | Stock Option/Right to Buy | 2022-02-11 | A | A | 12,434 | $0.00 | 12,434 | D | $225.00 · — to 2032-02-11 | 12,434 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023. |